CompletedNCT01458340
TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study is completed in the United States. It is testing TD-9855 for ADHD.
Multiple locations, including BradentonADHDOtherFrom 18 Years to 45 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT01617187
Asenapine for schizophrenia
This study is completed in Global. It is testing asenapine for schizophrenia.
In GlobalSchizophreniaOtherOver 18 Years
Active Not RecruitingNCT06254612
SP-624 for depression
This study is active but not recruiting in the United States. It is testing SP-624 for depression.
Multiple locations, including PhoenixDepressionOtherFrom 18 Years to 65 Years
CompletedNCT04115319
Safety study of investigational Drug in schizophrenia
This study is completed in the United States, in Romania, in Russia, .... It is testing investigational Drug for schizophrenia.
Multiple locations, including CerritosSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT03017781
The Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolarity
This study is completed in the United States. It is testing relationship of Psychosocial Function With Mood Symptoms for Bipolarity.
Multiple locations, including Culver CityBipolarityOtherFrom 15 Years to 25 Years
CompletedNCT06068465
Safety study of safety and Efficacy of Pimavanserin in Schizophrenia
This study is completed in China. It is testing safety and Efficacy of Pimavanserin for Schizophrenia.
Multiple locations, including HefeiSchizophreniaOtherOver 40 Years
CompletedNCT00650611
Safety study of ziprasidone in Schizophrenia
This study is completed in the United States. It is testing ziprasidone for Schizophrenia.
Multiple locations, including San DiegoSchizophrenia, BipolarityOtherFrom 10 Years to 17 Years
CompletedNCT04510298
Safety study of Safety, PK, and Exploratory Efficacy of SP-624 in schizophrenia
This study is completed in the United States. It is testing Safety, PK, and Exploratory Efficacy of SP-624 for schizophrenia.
Multiple locations, including Garden GroveSchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT02713282
Transition to the Paliperidone Palmitate 3-Month Formulation for schizophrenia
This study is completed in France, in the United Kingdom, in Croatia, .... It is testing Transition to the Paliperidone Palmitate 3-Month Formulation for schizophrenia.
Multiple locations, including RijekaSchizophreniaOtherFrom 18 Years to 50 Years
CompletedNCT00621777
Varenicline for Prevention of Relapse to Smoking in people with Schizophrenia or Bipolarity
This study is completed in the United States. It is testing varenicline for schizophrenia.
Multiple locations, including BirminghamBipolarity, SchizophreniaOtherFrom 18 Years to 70 Years
CompletedNCT04132557
A Study on Suicide prevention, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
This study is completed. It focuses on suicide prevention and currently lists study information in the United States.
In TitusvilleSuicidality, SchizophreniaOther
CompletedNCT05039489
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in China.
In ChangshaSchizophreniaOtherFrom 18 Years to 45 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.